Empresa Adverum Biotechnologies, Inc.
Acciones
ADVM
US00773U2078
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
10,43 USD | +4,30 % | +13,49 % | +38,55 % |
30/04 | ADVERUM BIOTECHNOLOGIES, INC. : HC Wainwright da una recomendación de compra | ZM |
29/04 | ADVERUM BIOTECHNOLOGIES, INC. : Mizuho Securities reitera su recomendación de compra | ZM |
Resumen de negocios
Número de empleados: 121
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Gene Therapeutics
100,0
%
| 0 | nan % | 4 | 100,0 % | - |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 4 | 100,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 15/06/20 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 12/12/22 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/21 |
Romuald Corbau
CTO | Chief Tech/Sci/R&D Officer | 55 | 29/01 |
Peter Soparkar
COO | Chief Operating Officer | 53 | 30/10/19 |
R. Ramelmeier
CTO | Chief Tech/Sci/R&D Officer | 62 | 21/08/23 |
Anand Reddi
HRO | Human Resources Officer | 42 | - |
Star Seyedkazemi
PRN | Corporate Officer/Principal | 50 | 06/01/22 |
Corporate Officer/Principal | - | 25/06/20 | |
Dena House
HRO | Human Resources Officer | - | 01/07/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 64 | 16/04/20 | |
Clarence Machado
CHM | Chairman | 60 | 14/03/17 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 15/06/20 |
Jim Scopa
BRD | Director/Board Member | 65 | 01/05/19 |
C. Nicholson
BRD | Director/Board Member | 68 | 03/11 |
Mark Lupher
BRD | Director/Board Member | 53 | 01/05/19 |
Reed Tuckson
BRD | Director/Board Member | 73 | 19/02/21 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 09/12/20 |
Rabia Ozden
BRD | Director/Board Member | 56 | 17/03/22 |
Soo Hong
BRD | Director/Board Member | 52 | 17/03/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 20 754 915 | 20 267 441 ( 97,65 %) | 0 | 97,65 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+38,55 % | 216 M | |
-1,43 % | 104 mil M | |
+8,96 % | 105 mil M | |
+4,40 % | 22,94 mil M | |
-12,15 % | 22,34 mil M | |
-4,36 % | 19,25 mil M | |
-39,98 % | 17,08 mil M | |
-10,04 % | 16,96 mil M | |
+6,79 % | 14,16 mil M | |
+38,61 % | 12,63 mil M |
- Bolsa de valores
- Acciones
- Acción ADVM
- Empresa Adverum Biotechnologies, Inc.